Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.
After finishing at $19.62 in the prior trading day, Kura Oncology Inc (NASDAQ: KURA) closed at $20.28, up 3.36%. In other words, the price has increased by $3.36 from its previous closing price. On the day, 0.75 million shares were traded. KURA stock price reached its highest trading level at $20.81 during the session, while it also had its lowest trading level at $19.63.
Ratios:
Our goal is to gain a better understanding of KURA by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 12.26 and its Current Ratio is at 12.26. In the meantime, Its Debt-to-Equity ratio is 0.04 whereas as Long-Term Debt/Eq ratio is at 0.04.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Mizuho on December 22, 2023, initiated with a Buy rating and assigned the stock a target price of $26.
On August 11, 2023, BofA Securities started tracking the stock assigning a Buy rating and target price of $31.
On July 27, 2023, Scotiabank started tracking the stock assigning a Sector Perform rating and target price of $10.50.Scotiabank initiated its Sector Perform rating on July 27, 2023, with a $10.50 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jan 30 ’24 when DALE STEPHEN sold 4,825 shares for $21.55 per share. The transaction valued at 103,980 led to the insider holds 38,817 shares of the business.
DALE STEPHEN sold 7,158 shares of KURA for $127,416 on Jan 29 ’24. The Chief Medical Officer now owns 43,642 shares after completing the transaction at $17.80 per share. On Jan 29 ’24, another insider, DOYLE THOMAS JAMES, who serves as the SVP, Finance & Accounting of the company, sold 2,318 shares for $17.80 each. As a result, the insider received 41,262 and left with 48,093 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, KURA now has a Market Capitalization of 1544942592 and an Enterprise Value of 1137300608.
Stock Price History:
The Beta on a monthly basis for KURA is 0.89, which has changed by 0.8090991 over the last 52 weeks, in comparison to a change of 0.23568535 over the same period for the S&P500. Over the past 52 weeks, KURA has reached a high of $24.17, while it has fallen to a 52-week low of $7.41. The 50-Day Moving Average of the stock is -1.57%, while the 200-Day Moving Average is calculated to be 45.76%.
Shares Statistics:
The stock has traded on average 950.13K shares per day over the past 3-months and 1026440 shares per day over the last 10 days, according to various share statistics. A total of 74.35M shares are outstanding, with a floating share count of 63.54M. Insiders hold about 16.54% of the company’s shares, while institutions hold 90.50% stake in the company. Shares short for KURA as of 1713139200 were 10118363 with a Short Ratio of 10.65, compared to 1710460800 on 10303199. Therefore, it implies a Short% of Shares Outstanding of 10118363 and a Short% of Float of 13.420000000000002.
Earnings Estimates
The performance of Kura Oncology Inc (KURA) in the stock market is under the watchful eye of 11.0 analysts actively contributing to its current rating.On average, analysts expect EPS of -$0.55 for the current quarter, with a high estimate of -$0.44 and a low estimate of -$0.68, while EPS last year was -$0.5. The consensus estimate for the next quarter is -$0.56, with high estimates of -$0.51 and low estimates of -$0.68.
Analysts are recommending an EPS of between -$2.0 and -$2.92 for the fiscal current year, implying an average EPS of -$2.32. EPS for the following year is -$2.46, with 13.0 analysts recommending between -$1.94 and -$3.1.
